These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 7812482

  • 1. Corticosteroids and peptic ulceration.
    Ellershaw JE, Kelly MJ.
    Palliat Med; 1994 Oct; 8(4):313-9. PubMed ID: 7812482
    [Abstract] [Full Text] [Related]

  • 2. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.
    Bjorkman DJ, Kimmey MB.
    Dig Dis; 1995 Oct; 13(2):119-29. PubMed ID: 7586632
    [Abstract] [Full Text] [Related]

  • 3. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A.
    Br J Hosp Med; 1995 Oct; 49(11):767-72. PubMed ID: 8101464
    [Abstract] [Full Text] [Related]

  • 4. The epidemiology of NSAID associated gastrointestinal disease.
    Wolfe F.
    Eur J Rheumatol Inflamm; 1991 Oct; 11(3):12-28. PubMed ID: 1365476
    [Abstract] [Full Text] [Related]

  • 5. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 6. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 7. Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
    Marcus P, McCauley DL.
    Clin Pharmacol Ther; 1997 May; 61(5):503-8. PubMed ID: 9164412
    [No Abstract] [Full Text] [Related]

  • 8. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct 25; 149(43):58-9. PubMed ID: 17992910
    [No Abstract] [Full Text] [Related]

  • 9. [How to reduce the risks of NSAIDs].
    Gross M.
    MMW Fortschr Med; 2008 Jul 31; 150(28-31):50-3; quiz 54. PubMed ID: 19006892
    [No Abstract] [Full Text] [Related]

  • 10. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May 20; 152(20):46-7. PubMed ID: 20552882
    [No Abstract] [Full Text] [Related]

  • 11. [Prophylaxis and treatment of NSAID-related peptic ulceration: present status and prospects].
    Hiraishi H, Akima T, Sugaya T, Nakano M, Nomura M.
    Nihon Rinsho; 2011 Jun 20; 69(6):988-94. PubMed ID: 21688617
    [Abstract] [Full Text] [Related]

  • 12. Corticosteroids and ulcers: is there an association?
    Pecora PG, Kaplan B.
    Ann Pharmacother; 1996 Jun 20; 30(7-8):870-2. PubMed ID: 8826575
    [Abstract] [Full Text] [Related]

  • 13. Surgery in the management of the gastric side-effects of NSAIDs.
    Venables CW.
    Aliment Pharmacol Ther; 1988 Jun 20; 2 Suppl 1():97-111. PubMed ID: 2979288
    [Abstract] [Full Text] [Related]

  • 14. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.
    Gastroenterology; 2007 Sep 20; 133(3):790-8. PubMed ID: 17854591
    [Abstract] [Full Text] [Related]

  • 15. Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity.
    Griffin MR, Scheiman JM.
    Am J Med; 2001 Jan 08; 110(1A):33S-37S. PubMed ID: 11165994
    [Abstract] [Full Text] [Related]

  • 16. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids.
    Henry DA, Johnston A, Dobson A, Duggan J.
    Br Med J (Clin Res Ed); 1987 Nov 14; 295(6608):1227-9. PubMed ID: 3120956
    [Abstract] [Full Text] [Related]

  • 17. [Frequency and severity of gastric and duodenal lesions induced by non-steroidal anti-inflammatory agents and aspirin].
    Florent C, Desaint B.
    Gastroenterol Clin Biol; 1989 Mar 14; 13(3):235-8. PubMed ID: 2731675
    [No Abstract] [Full Text] [Related]

  • 18. [Ulcer prevention during anti-rheumatism therapy and in intensive medicine].
    Koelz HR.
    Schweiz Rundsch Med Prax; 1994 Jun 21; 83(25-26):768-71. PubMed ID: 8029591
    [Abstract] [Full Text] [Related]

  • 19. Selective COX-2 inhibitors: a promise unfulfilled?
    Henry D, McGettigan P.
    Gastroenterology; 2007 Feb 21; 132(2):790-4. PubMed ID: 17261306
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.